|TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors||
||680||All||18 Years to 99 Years (Adult, Senior)||NCT00543725||CR002704
|June 2008||January 2010||February 2012||October 15, 2007||April 1, 2016||July 12, 2011||
|2||NCT03251690||Active, not recruiting||Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression||
||244||All||18 Years and older (Adult, Senior)||NCT03251690||ID09-59-06||STEREOS||October 27, 2016||March 31, 2018||March 31, 2018||August 16, 2017||January 24, 2018|
† Study has passed its completion date and status has not been verified in more than two years.